Posted by AGORACOM
at 11:13 PM on Thursday, March 12th, 2020
Vertical Exploration is developing its St. Onge Wollastonite as a soil additive for optimizing marijuana growth. Recently engaged AGRINOVA’s Phase 1 Reseach program also demonstrated Wollastonite can potentially become BNQ certified for agricultural use in Quebec. Recently signed distribution agreement with AREV Brands International to Supply St-Onge Wollastonite to the Cannabis and Hemp Industries. Click Here for More Info.
Definitive
distribution agreement to partner on the sale of Vertical’s
wollastonite from its world-class St-Onge Deposit in place.
Supplying the fast growing cannabis and hemp industries.
Vertical’s high quality Wollastonite has been shown to be beneficial to cannabis plants in a variety of ways
In every case the most optimal results occurred with an admixture rate of 10% to 15% wollastonite to the growth medium.
The
high-grade St-Onge Wollastonite deposit has pit-constrained mineral
resources of: 7,155,000 tonnes Measured@ 36.20% Wollastonite &
6,926,000 tonnes Indicated@ 37.04%
B.C. Buds Testing Confirmed Wollastonite is critical to marijuana growers
Engaged
AGRINOVA over the past year to conduct research and testing of
Vertical’s St-Onge wollastonite on a range of important agricultural end
uses.
WOLLASTONITE
St-Onge-Wollastonite
Deposit located approximately 90 kilometres Northwest of the city of
Saguenay, in St-Onge township, in the Saguenay-Lac-St-Jean region of
Quebec, Canada.
Research and testing in the Phase 1 program for use in cannabis growth was managed and monitored by AGRINOVA, a highly-regarded Center for Research and Innovation in Agriculture in Quebec
Reported (Q3-2019) revenues of $1,683,985 compared to $589,648, up by 186%
For the nine months operations, company reported revenues of $2,559,068 compared to $1,872,944, up by 37%
Cash position improved significantly, $812,853 compared to $66,296 in the previous quarter
Recent Achievements:
Secured the second contract of a multi
phase R&D program through the Department of National Defence’s
Innovation for Defence Excellence and Security (IDEaS) program with a
value of approximately $945,094.
Software licencing contract with
GreenInsightz Limited for the use of its proprietary Nexalogy’s
Artificial Intelligence software platform for a value of approximately
$1 million in cash and shares
Secured another contract with a division of Lotte for approximately $1,000,000.
Participated in NATO Research Task Group in Paris, France.
The Technology:
NexaIntelligence
Social-media discovery and monitoring platform for those who need to extract actionable insights out of discussions to inform decision-making.
Current languages supported: English, French, Russian, and Korean (more coming soon).
The system collects and analyses data from Twitter, Facebook, Tumblr, blogs, web forums, online news sites, Google Alerts and RSS feeds. With it, you’ll be able to make qualitative analyses based on both quantitative and qualitative data so you can provide context for the numbers, not just spreadsheets.
When exploring Twitter data, users immediately have access to:
An interactive timeline showing peaks of activity
Most frequent publishers and most frequently mentioned accounts
Most common words and hashtags
A lexical map that automatically clusters conversations to show common patterns of interactions and key topics
A geolocation-based heat map
FULL DISCLOSURE: Datametrex AI Limited is an advertising client of AGORA Internet Relations Corp.
Physician Groups Order The Heartcheck(TM) Cardibeat For In-Home Arrhythmia And Atrial Fibrillation Monitoring
Confirms market traction with orders being placed by physician
groups for the newly launched HeartCheck™ CardiBeat Handheld ECG monitor
and GEMS™ Mobile Smartphone app for prescribed in-home arrhythmia
monitoring.
Partners in Advanced Cardiac Evaluation, the largest arrhythmia
practice in Ontario (Canada) placed a first order of the HeartCheck™
CardiBeat Handheld ECG monitors and is recommending its patients to use
the devices for one year of in-home, self-monitoring with an emphasis on
detecting a recurrence of Atrial Fibrillation following cardiac
ablation treatment for AF.
30% Of Acquisition Price Paid If Venom Revenues Hit $30,000,000 and $40,000,000 By DEC 31, 2021
Average revenue per gram YTD 2019 $CDN 14 and will continue to increase as vape cartridge mix grows ($CDN 30 per gram)
One Of Arizona’s Largest Producers Of Award-Winning Medical Cannabis Distillate
Acquisition Expected To Close By March 31, 2020 Subject To Due Diligence
An established brand in Arizona for high quality
products in the wholesale and distillate marketplace. Venom is
leveraging its brand and success to aggressively expand into other US
states.
ACQUISITION TERMS
Hollister will acquire Venom Extracts for CDN$20,000,000 via Hollister stock
The stock price will be determined based on the greater of:
The 14-day VWAP (Volume Weighted Average Price) capped at $0.25 subsequent to announcing the transaction and $0.20
Once share price is established, 70% of the Payment Shares will be issued upon closing of the transaction
Remaining
30% of the Payment Shares will be issued when and if the following
milestones have been met on or prior to December 31st, 2021
Posted by AGORACOM-JC
at 2:32 PM on Tuesday, February 4th, 2020
Salinas greenhouse facility is currently operating 60,000 sq. ft. licensed canopy and contains ample room for expansion. The facility is also licensed for manufacturing and for distribution.
In late December completed first harvest at Salinas, California cultivation facility.
Harvested 2,687 plants that were included in the acquisition of the Qlora Group.
Anticipates completing testing and sale of the product in late January 2020, which will represent the first revenue generated by the Company in California.
Also completed an in-depth review and analysis of both the infrastructure and cultivation practices and will be implementing significant efficiencies over the course of the next four harvests.
Anticipates continual harvests of 2,000-3,000 plants every 25 days, with quality and yield improving with each harvest.
Product will be sold via wholesale agreements to existing Qlora clients in the interim as company prepares for the launch of NORTHBUD branded flower products in California in the third quarter of 2020.Â
Cannabis Production Facility in Reno, Nevada
Assumed control of Nevada operation licensed for cultivation, manufacturing and distribution throughout the state.
Announced the completion of the first harvest of approximately 175 indoor grown plants
Upon the completion of testing and processing, the product will be
distributed as NORTHBUD flower, pre-rolls and infused pre-rolls into
selected Nevada dispensaries.
The launching of NORTHBUD branded products into Nevada marks a significant milestone for the Company.
Request for Outdoor Cultivation License:
In the context of a regular follow-up communication with Health
Canada, representatives of the Company received verbal feedback that the
application review is complete and the reviewers do not have any more
questions
Subject to the re-submission of a required foreign police
certificate related to one of the foreign directors of the Company, the
Company will be in the final queue for receiving its licence.
The Company is confident that it will be able to file the
certificate promptly; however, there can be no assurance as to the exact
timing of the issuance of the licence by Health Canada or whether the
Company will receive any final request from Health Canada.
FULL DISCLOSURE: NORTHBUD is an advertising client of AGORA Internet Relations Corp.
Physician Groups Order The Heartcheck(TM) Cardibeat For In-Home Arrhythmia And Atrial Fibrillation Monitoring
Confirms market traction with orders being placed by physician
groups for the newly launched HeartCheck™ CardiBeat Handheld ECG monitor
and GEMS™ Mobile Smartphone app for prescribed in-home arrhythmia
monitoring.
Partners in Advanced Cardiac Evaluation, the largest arrhythmia
practice in Ontario (Canada) placed a first order of the HeartCheck™
CardiBeat Handheld ECG monitors and is recommending its patients to use
the devices for one year of in-home, self-monitoring with an emphasis on
detecting a recurrence of Atrial Fibrillation following cardiac
ablation treatment for AF.
Posted by AGORACOM-JC
at 12:35 PM on Tuesday, January 7th, 2020
Investment Highlights
Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property
Kenbridge Ni Project (ON, Canada)
Advanced stage deposit remains open in three directions, is
equipped with a 623m deep shaft and has never been mined
Preliminary Economic Assessment completed and updated returned robust project economics and operating costs including a NPV of C$253M and cash costs of US$3.47/lb of nickel net of copper credits
Plans for Kenbridge include updating PEA,
advancing the project through to feasibility and exploring the open
mineralization at depth
Posted by AGORACOM-JC
at 5:29 PM on Monday, December 30th, 2019
Investment Highlights
Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property
Kenbridge Ni Project (ON, Canada)
Advanced stage deposit remains open in three directions, is
equipped with a 623m deep shaft and has never been mined
Preliminary Economic Assessment completed and updated returned robust project economics and operating costs including a NPV of C$253M and cash costs of US$3.47/lb of nickel net of copper credits
Plans for Kenbridge include updating PEA,
advancing the project through to feasibility and exploring the open
mineralization at depth
Company collaborates with ZANA Technologies GmbH to integrate mobile ECG management and Smartphone App technologies
ECG technologies to be tested within ZANA’s remote patient monitoring platform in 2020
CardioComm’s GEMS™ ECG reviewing and HeartCheck™ ECG monitoring
technologies are being evaluated to support ZANA’s novel,
voice-directed, remote patient monitoring and patient management
platform.
/north-bud-company/Salinas_California_northbud-i0b12.jpg)
/north-bud-company/P1350266-s3086.png)
